Project: Coronavirus Research
CHIBE is proud that our faculty have worked hard to respond to the COVID-19 pandemic, creating numerous programs locally and nationally, generating scholarship, and providing thought leadership to guide the pandemic response worldwide.
Our faculty engaged with policymakers in a variety of ways to help with the COVID-19 vaccine roll-out. CHIBE Scientific Director Dr. Alison Buttenheim provided testimony on vaccine acceptance to the U.S. House of Representatives’ Committee on Science, Space, and Technology. In her testimony, Dr. Buttenheim provided several science-based recommendations that she hoped Congress would endorse, fund, and promote.
Dr. Buttenheim and CHIBE-affiliated faculty member Dr. Daniel Polsky were appointed to a National Academies of Sciences, Engineering, and Medicine ad-hoc committee on equitable allocation of COVID-19 vaccines.
Dr. Buttenheim also participated in the Philadelphia Department of Public Health COVID-19 Vaccine Advisory Committee and helped convene three Behavioral Science and COVID-19 Vaccine Acceptance conversations that were co-hosted by CHIBE.
CHIBE-affiliated faculty member Dr. Harald Schmidt also provided public comments at the U.S. Department of Health and Human Services’ COVID Health Equity Task Force.
In addition, Drs. Buttenheim, Angela Duckworth, Gretchen Chapman, and Adam Grant (all CHIBE affiliates) contributed to COVID-19 Vaccination Uptake Behavioral Science Task Force report for the CMS Chief Medical Officer and Director of the Center for Clinical Standards and Quality for distribution to the Department of Health & Human Services.
On our COVID-19 research page, you can see some of the other ways in which our faculty and staff have contributed, through the creation of models to support COVID-19 patient care, through the development of public health prevention initiatives, in providing guidance to health systems, and in educating the public through media and social media communications, and much more.